- ORCID iD
-
0000-0002-3341-3261
Show
Sort by
-
Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer
-
- Conference Paper
- C3
- open access
Assessing recovery rates of mesenchymal and epithelial pancreatic tumor cells using the Parsortix system
-
- Conference Paper
- C3
- open access
Liquid biopsies to predict surgical resectability after FOLFIRINOX chemotherapy in patients with locally advanced and borderline resectable pancreatic ductal adenocarcinoma